Garcinia cowa Bark Extract Attenuates Collagen-Induced Arthritis in Rats by Inhibiting Oxidative Stress
Background
Rheumatoid arthritis (RA) is a debilitating autoimmune disorder characterized by chronic synovial inflammation, progressive joint destruction, and significant oxidative stress. Current treatments often involve immunosuppressants and biologics, which can have substantial side effects or fail to fully address disease progression. There is a continuous need for adjunctive therapies that can mitigate inflammation and oxidative damage, key drivers of RA pathology, with a favorable safety profile. This study investigates Garcinia cowa bark extract (GC) as a potential natural intervention, focusing on its ability to modulate redox status and inflammatory cytokines in an RA model.
Study Design
Researchers induced collagen-induced arthritis (CIA) in rats to mimic human RA. Animals were orally administered Garcinia cowa bark extract (GC) at doses of 1.25-5 mg/kg body weight, p.o., daily from days 11 to 27 post-immunization. Throughout the treatment period, paw edema and arthritis scores were regularly monitored. On day 28, rats were sacrificed, and bone architecture was assessed using radiography and histopathology. Redox status in paw tissue was quantified via myeloperoxidase (MPO) activity, protein carbonylation, lipid peroxidation, and total antioxidant capacity using FRAP and DPPH assays. Additionally, IL-6 and IL-10 levels were measured by ELISA.
Results
In the collagen-induced arthritis (CIA) model, significant joint damage, enhanced oxidative stress, and elevated levels of IL-6 and IL-10 were observed. Pre-treatment with GC (5 mg/kg b.w.) effectively prevented the progression of arthritis, evidenced by a notable reduction in paw edema and arthritic score compared to untreated CIA controls. Histopathological and radiographic analyses confirmed that GC attenuated bony and cartilaginous damage. Furthermore, GC improved splenic and thymic indices, suggesting a positive impact on immune organ health.
GC (5 mg/kg b.w.) significantly reduced levels of both the pro-inflammatory cytokine
IL-6and the regulatory cytokineIL-10, indicating a modulation of the inflammatory response. This extract also restored redox balance, as evidenced by a reduction inMPOactivity, protein carbonylation, and lipid peroxidation, alongside a substantial increase in total antioxidant capacity.
Key Findings
- Garcinia cowa bark extract (GC) prevented arthritis progression in a rat CIA model.
- GC (5 mg/kg) significantly reduced paw edema and arthritic scores.
- GC attenuated bony and cartilaginous joint damage in arthritic rats.
- GC restored redox balance by reducing MPO, protein carbonylation, and lipid peroxidation.
- GC lowered inflammatory cytokine levels of IL-6 and IL-10.
Why It Matters
This study highlights Garcinia cowa bark extract (GC) as a promising natural compound for managing rheumatoid arthritis (RA), particularly through its potent antioxidant and anti-inflammatory properties. For individuals seeking complementary approaches, this suggests a potential adjunctive role for botanical extracts in mitigating disease progression and symptoms. The oral administration route and observed efficacy in reducing joint damage and oxidative stress offer a compelling avenue for further investigation. While this is a preclinical animal study, the findings provide a mechanistic basis for how GC could improve outcomes by targeting core pathological processes like oxidative stress and cytokine dysregulation. Future research should focus on human clinical trials to establish optimal dosing, long-term safety, and efficacy in diverse patient populations, potentially paving the way for its integration into RA management protocols.
garcinia-cowa
rheumatoid-arthritis
inflammation
oxidative-stress
animal-study
anti-inflammatory